Managing potential supply issues with medicines during Coronavirus (COVID-19)

Marketing authorisation holders are advised to provide the MHRA with information about any supply issues they are experiencing, as a result of COVID-19 to help the Agency manage the supply of medicines and other healthcare products.

Medicines and Healthcare products Regulatory Agency